The roles of epigenetic modifications of proapoptotic BID and BIM genes in imatinib-resistant chronic myeloid leukemia cells

Author： Bozkurt S黵eyya  

Publisher： Maney Publishing

ISSN： 1024-5332

Source： Hematology, Vol.18, Iss.4, 2013-07, pp. : 217-223

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Imatinib Mesylate in Chronic Myeloid Leukemia

By  

Current Stem Cell Research & Therapy, Vol. 2, Iss. 3, 2007-09 ,pp. : 249-251

Bentham Science Publishers

Access to resources Recommend Favorite

Mechanisms of cellular resistance to imatinib in human chronic myeloid leukemia cells

By Baran Yusuf   Ural Ali Ugur   Gunduz Ufuk  

Hematology, Vol. 12, Iss. 6, 2007-12 ,pp. : 497-503

Maney Publishing

Access to resources Recommend Favorite

Imatinib induces autophagy through BECLIN-1 and ATG5 genes in chronic myeloid leukemia cells

By Can Geylani   Ekiz Huseyin Atakan   Baran Yusuf  

Hematology, Vol. 16, Iss. 2, 2011-03 ,pp. : 95-99

Maney Publishing

Access to resources Recommend Favorite

Docetaxel enhances the cytotoxic effects of imatinib on Philadelphia positive human chronic myeloid leukemia cells

By Gucluler Gozde   Baran Yusuf  

Hematology, Vol. 14, Iss. 3, 2009-06 ,pp. : 139-144

Maney Publishing

Access to resources Recommend Favorite

Μultiple myeloma developing after imatinib mesylate therapy for chronic myeloid leukemia

By Galanopoulos A.  

Annals of Hematology, Vol. 88, Iss. 3, 2009-03 ,pp. : 281-282

Springer Publishing Company

Access to resources Recommend Favorite